SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (195)11/16/1997 1:24:00 PM
From: James Baker  Read Replies (1) of 569
 
John:
My E.P.S. estimates for BIOX are:

1997 - $1.36
1998 - $2.28

Now I like this comparison much better!!! >60% yr over yr growth.

And yes you restated my thoughts very well.
A few patients are probably so afftected by OA that only surgery will give them relief. I think that the great majority should find twice a yr series of SYNVISC injections a great alternative to daily doses of NSAIDS with their cost and potential side effects. Primary care docs "need" more services that they can in good faith offer to their patients. I see SYNVISC as a great treatment for patients and another source of revenue to primary care. A true win-win situation.
Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext